Opioid prescribing to older cancer survivors: a retrospective claims-based characterization of prescriber specialties
Journal of Cancer Survivorship · 2026-10 · 20 (5) · 2431-2446
DOI: 10.1007/s11764-025-01944-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Survivorship, online erschienen am 29.11.2025. Verfasst von Talya Salz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, 633 3rd Avenue, 3rd floor, New York, NY, 10017, USA. salzt@mskcc.org. Hauptthemen laut MEDLINE: Analgesics, Opioid, Practice Patterns, Physicians', Cancer Survivors, Drug Prescriptions. Die Arbeit nennt 58 Literaturangaben. Gefördert von: NCI NIH HHS, US National Institute of Health, Beatrice and Samuel A. Seaver Foundation Program in Cancer and Aging.
Abstract (Originalsprache)
PURPOSE: Older cancer survivors have concerning rates of unsafe opioid prescribing. Little is known about the specialty of providers prescribing to survivors, which is essential to guide interventions. METHODS: Using SEER-Medicare data, we identified adults age > 65 diagnosed 2014-2017 with stage I-III female breast, lung, or colorectal cancer with ≥6 months treatment-free follow-up through 2019. Each opioid filled after treatment completion was assigned to a prescriber specialty: oncology, surgery, primary care, pain medicine, or other. Generalized estimating equation models captured the relative likelihood of an opioid being prescribed by each provider specialty. RESULTS: Among 69,769 survivors, 46% of breast, 49% of colorectal, and 49% of lung cancer survivors filled ≥1 opioid prescription during follow-up. For all three cancers, primary care providers (PCPs) prescribed a greater share of opioid fills (50%-56%) than other specialists, prescribed opioids to a greater share of survivors (49%-56%) than other specialists, and prescribed opioids for longer durations (median 30 days/year) than oncologists and surgeons. The likelihood of an opioid being prescribed by an oncologist was up to 9 times lower than that of it being prescribed by a PCP: probability ratios 0.11 (95% CI 0.10-0.13) for breast, 0.12 (95% CI, 0.10-0.14) for colorectal, and 0.15 (95% CI, 0.13-0.17) for lung cancer survivors. CONCLUSION: PCPs are highly involved in prescribing opioids to older survivors of common cancers. Interventions to enhance pain management for survivors should target primary care. IMPLICATIONS FOR CANCER SURVIVORS: As survivors transition away from oncology-based care, oncologists must communicate with PCPs about ongoing pain and opioid prescribing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, 633 3rd Avenue, 3rd floor, New York, NY, 10017, USA. salzt@mskcc.org.
- Memorial Sloan Kettering Cancer Center, 633 3rd Avenue, 3rd floor, New York, NY, 10017, USA.
- University of California, San Diego, La Jolla, CA, USA.
Förderung
- NCI NIH HHS
- US National Institute of Health
- Beatrice and Samuel A. Seaver Foundation Program in Cancer and Aging
Zitieren
APA
Salz, T., Meza, A. M., Jinna, S., Moryl, N., Kriplani, A., Tringale, K. R., Flory, J., & Lipitz-Snyderman, A. (2026). Opioid prescribing to older cancer survivors: a retrospective claims-based characterization of prescriber specialties. Journal of Cancer Survivorship, 20(5), 2431-2446. https://doi.org/10.1007/s11764-025-01944-9
Vancouver
Salz T, Meza AM, Jinna S, Moryl N, Kriplani A, Tringale KR, et al. Opioid prescribing to older cancer survivors: a retrospective claims-based characterization of prescriber specialties. Journal of Cancer Survivorship. 2026;20(5):2431-2446. doi:10.1007/s11764-025-01944-9
BibTeX
@article{Salz2026,
author = {Salz, Talya and Meza, Akriti Mishra and Jinna, Sankeerth and Moryl, Natalie and Kriplani, Anuja and Tringale, Kathryn R and Flory, James and Lipitz-Snyderman, Allison},
title = {Opioid prescribing to older cancer survivors: a retrospective claims-based characterization of prescriber specialties},
journal = {Journal of Cancer Survivorship},
year = {2026},
volume = {20},
number = {5},
pages = {2431--2446},
doi = {10.1007/s11764-025-01944-9}
}
EUVIMED